BDBM50014908 4-(2-Chloro-3-trifluoromethyl-phenyl)-2-imidazol-1-ylmethyl-6-methyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester : (succinate)::CHEMBL351385
SMILES: CCOC(=O)C1=C(Cn2ccnc2)N=C(C)C(C1c1cccc(c1Cl)C(F)(F)F)C(=O)OC
InChI Key: InChIKey=DAZUMWBSSONIGJ-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thromboxane A2 Synthase (P450 TxA2) (Homo sapiens (Human)) | BDBM50014908 (4-(2-Chloro-3-trifluoromethyl-phenyl)-2-imidazol-1...) | KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Wyeth Research UK Curated by ChEMBL | Assay Description Inhibition of Thromboxane A2 synthetase after oral administration of 0.03 mmol/kg | J Med Chem 33: 646-52 (1990) BindingDB Entry DOI: 10.7270/Q25X29HP | |||||||||||
More data for this Ligand-Target Pair |